Amarantus BioScience Holdings, Inc.
OTC: AMBS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John Wesley Commissiong
- Employees
- 12
- Headquarters
- New York City, United States
- IPO year
- 2010
- Market cap
- $36.8K
- Website
- https://www.amarantus.com
Loading AMBS…
Loading profile data…Frequently asked questions about AMBS
What does Amarantus BioScience Holdings, Inc. (AMBS) do?
Amarantus BioScience Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating innovative diagnostic tools and therapeutic solutions. Its primary focus areas encompass neurological disorders, psychiatric conditions, eye-related ailments (ophthalmology), and regenerative medicine. The company's diagnostic pipeline includes th...
Where does AMBS trade?
Amarantus BioScience Holdings, Inc. (AMBS) trades on the Other OTC.
What sector is AMBS in?
Amarantus BioScience Holdings, Inc. (AMBS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Amarantus BioScience Holdings, Inc.?
John Wesley Commissiong is the chief executive officer of Amarantus BioScience Holdings, Inc. (AMBS).
Where is Amarantus BioScience Holdings, Inc. headquartered?
Amarantus BioScience Holdings, Inc. is headquartered in United States.
Does AMBS pay a dividend?
Amarantus BioScience Holdings, Inc. (AMBS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AMBS go public?
Amarantus BioScience Holdings, Inc. (AMBS) completed its initial public offering in 2010.